CD9 and metabolic dysfunction-associated steatotic liver disease: These markers have been reported to identify a peculiar subset of hepatic macrophages emerging in conditions of either human of murine progressive NAFLD (19–21, 46, 47) showing similarities with TREM2 CD9 expressing scar-associated macrophages (SAMs).